Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders
The ephemeral placenta provides a noncontroversial source of young, healthy cells of both maternal and fetal origin from which cell therapy products can be manufactured. The 2 advantages of using live cells as therapeutic entities are: (a) in their environmental-responsive, multifactorial secretion...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-01-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/0963689717727543 |